Defective signal transduction induced by thromboxane A2 in a patient with a mild bleeding disorder: impaired phospholipase C activation despite normal phospholipase A2 activation
- PMID: 8428006
Defective signal transduction induced by thromboxane A2 in a patient with a mild bleeding disorder: impaired phospholipase C activation despite normal phospholipase A2 activation
Abstract
A patient with a mild bleeding disorder whose platelets responded defectively to thromboxane A2 (TXA2) was identified, and the mechanism of this dysfunction was analyzed. The platelets were defective in shape change, aggregation, and release reaction in response to synthetic TXA2 mimetic (STA2). When the platelet TXA2 receptor was examined with both a 125I-labeled derivative of a TXA2 receptor antagonist ([125I]-PTAOH) and [3H]-labeled TXA2 agonist ([3H]U-46619), the equilibrium dissociation rate constants (kd) and the maximal concentrations of binding sites (Bmax) of the platelets to both ligands were within normal ranges, suggesting that the binding capacity of their TXA2 receptor was normal. STA2 could not induce IP3 formation and intracellular Ca2+ mobilization, whereas these responses to thrombin were within normal ranges. GTPase activity was also decreased when the patient's platelet membrane was challenged with STA2. On the other hand, lysophosphatidylinositol formation, which is a direct indicator of phospholipase A2 (PLA2) activation, was found to be normal when the [3H]-inositol-labeled platelets were challenged with STA2. Thromboxane B2 (TXB2) was also produced in response to STA2. These results suggested that the abnormality in these platelets was impaired coupling between TXA2 receptor and phospholipase C (PLC) activation. Furthermore, it is also suggested that the activation of PLA2 and PLC are separable events in thromboxane-induced platelet activation.
Similar articles
-
Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.J Clin Invest. 1993 Nov;92(5):2469-79. doi: 10.1172/JCI116855. J Clin Invest. 1993. PMID: 8227362 Free PMC article.
-
Defective signal transduction through the thromboxane A2 receptor in a patient with a mild bleeding disorder: deficiency of the inositol 1,4,5-triphosphate formation despite normal G-protein activation.Thromb Haemost. 1997 May;77(5):991-5. Thromb Haemost. 1997. PMID: 9184416
-
Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets.Br J Pharmacol. 1996 Mar;117(6):1095-104. doi: 10.1111/j.1476-5381.1996.tb16702.x. Br J Pharmacol. 1996. PMID: 8882602 Free PMC article.
-
Properties and regulation of human platelet cation channels.EXS. 1993;66:281-8. doi: 10.1007/978-3-0348-7327-7_22. EXS. 1993. PMID: 8268709 Review.
-
Platelet and vascular smooth muscle thromboxane A2/prostaglandin H2 receptors.Fed Proc. 1987 Jan;46(1):149-53. Fed Proc. 1987. PMID: 2948839 Review.
Cited by
-
A novel thromboxane A2 receptor D304N variant that abrogates ligand binding in a patient with a bleeding diathesis.Blood. 2010 Jan 14;115(2):363-9. doi: 10.1182/blood-2009-08-236976. Epub 2009 Oct 14. Blood. 2010. PMID: 19828703 Free PMC article.
-
Platelet signal transduction defect with Galpha subunit dysfunction and diminished Galphaq in a patient with abnormal platelet responses.Proc Natl Acad Sci U S A. 1997 Aug 5;94(16):8750-5. doi: 10.1073/pnas.94.16.8750. Proc Natl Acad Sci U S A. 1997. PMID: 9238049 Free PMC article.
-
Two thromboxane A2 receptor isoforms in human platelets. Opposite coupling to adenylyl cyclase with different sensitivity to Arg60 to Leu mutation.J Clin Invest. 1996 Feb 15;97(4):949-56. doi: 10.1172/JCI118518. J Clin Invest. 1996. PMID: 8613548 Free PMC article.
-
Thromboxane-insensitive dog platelets have impaired activation of phospholipase C due to receptor-linked G protein dysfunction.J Clin Invest. 1993 Nov;92(5):2469-79. doi: 10.1172/JCI116855. J Clin Invest. 1993. PMID: 8227362 Free PMC article.
-
Arg60 to Leu mutation of the human thromboxane A2 receptor in a dominantly inherited bleeding disorder.J Clin Invest. 1994 Oct;94(4):1662-7. doi: 10.1172/JCI117510. J Clin Invest. 1994. PMID: 7929844 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous